Pancreatic Insufficiency in Patients Under Sorafenib Treatment for Hepatocellular Carcinoma.

Journal of Clinical Gastroenterology
Álvaro Díaz-GonzálezMaría Reig

Abstract

To describe the occurrence of malabsorption (MA) in hepatocellular carcinoma (HCC) patients under sorafenib, the potential relationship with pancreatic insufficiency (PI), and the role of pancreatic enzymes supplementation. With the increasing options of second-line systemic therapies for HCC, the recognition of drug intolerance using practical tools is crucial. It has been proposed that a MA syndrome could be due to sorafenib-induced pancreatic dysfunction. All sorafenib-treated patients with suspicion of MA (defined as decreased stool consistency lasting >4 wk or presenting ≥10% body weight loss without HCC progression) were prospectively evaluated by serum markers, endoscopy, and imaging techniques. We evaluated 81 sorafenib-treated patients and 21 developed MA suspicion (85.7% male, 81.5% Child-Pugh A, 52.4% BCLC-B, and 47.6% BCLC-C) within a median 5.9 months after starting sorafenib. The median treatment duration, follow-up, and overall survival after MA suspicion were 5.9, 20.3, and 20.3 months, respectively. Nine of them (42.9%) presented hyperparathyroidism secondary to vitamin D deficiency and 8 with PI. A gradual decrease in pancreatic volume of up to 19% was observed among patients with PI. Six of the 8 patients wit...Continue Reading

References

May 29, 1999·Gastroenterology·K D Fine, L R Schiller
Apr 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael W N DeiningerBrian J Druker
Sep 21, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Tomomi KambaDonald M McDonald
Jun 2, 2007·Biochemical and Biophysical Research Communications·Miyako TakakiKazuhide Horiguchi
Sep 10, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wen ZhengJörn Karhausen
Feb 16, 2011·Laboratory Investigation; a Journal of Technical Methods and Pathology·Mengde CaoChen Liu
Jul 20, 2011·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Francis J ScholzSpencer C Behr
Nov 8, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O MirF Goldwasser
Jan 23, 2013·International Immunopharmacology·Jiunn-Chang LinYu-Jen Chen
Jul 3, 2013·International Journal of Cancer. Journal International Du Cancer·Mei-Ling ChenAnn-Lii Cheng
Feb 1, 2015·Abdominal Imaging·Mark E BakerJoel G Fletcher
Jun 16, 2015·Cancer Treatment Reviews·Ysabella Z A Van SebilleJoanne M Bowen
Jun 28, 2015·The Journal of Surgical Research·Li XuTimothy M Pawlik
Jul 15, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sumanta K PalPaul Frankel
Apr 4, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ChaputF Carbonnel
Jul 5, 2018·The New England Journal of Medicine·Ghassan K Abou-AlfaRobin K Kelley
Dec 4, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard S FinnUNKNOWN KEYNOTE-240 investigators
Jan 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O MirF Goldwasser

❮ Previous
Next ❯

Citations

Jul 7, 2021·United European Gastroenterology Journal·Álvaro Díaz-GonzálezMaría Reig

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies

Software Mentioned

STATA

Related Concepts

Related Papers

The New England Journal of Medicine
Stephen Sullivan
The New England Journal of Medicine
Ségolène HescotFrançois Goldwasser
© 2022 Meta ULC. All rights reserved